Wuhan YZY Biopharma Co Ltd

Rachunek Zysków i Strat


index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2021 2021 2022 2022 2022 2023 2023 2023 2023 2024 2024
Kwartał Q2 Q4 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
Data 2021-06-30 2021-12-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Przychód (mln) 0 0 0 1 1 4 4 3 3 1 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% inf% inf% inf% 341.3% 341.3% -63.14% -100.00%
Marża brutto -inf% -inf% -inf% 100.0% -492.47% 100.0% -11.64% 100.0% -38.23% 100.0% -inf%
Koszty i Wydatki (mln) 58 117 109 55 98 53 90 59 105 42 90
EBIT (mln) -58 -117 -109 -48 -98 -42 -90 -49 -105 -40 -90
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 70.6% -64.14% -17.07% 3.7% 7.1% -3.63% -0.05%
EBIT (%) 0.0% 0.0% 0.0% -7505.65% -15081.48% -1086.05% -2484.05% -1763.50% -3659.14% -2839.14% 0.0%
Przychody fiansowe (mln) 0 0 0 1 0 1 0 0 1 0 2
Koszty finansowe (mln) 1 0 1 0 2 0 2 0 1 0 2
Amortyzacja (mln) 5 4 4 2 4 2 4 2 4 2 4
EBITDA (mln) -53 -112 -105 -46 -94 -40 -86 -48 -101 -39 -86
EBITDA(%) 0.0% 0.0% 0.0% -7231.00% -14489.01% -1038.90% -2372.41% -1701.61% -3520.90% -2724.65% 0.0%
NOPLAT (mln) -68 -111 -108 -55 -111 -49 -98 -56 -114 -39 -85
Podatek (mln) 0 -0 0 0 -0 0 0 0 0 0 -0
Zysk Netto (mln) -68 -111 -108 -55 -111 -49 -98 -56 -114 -39 -85
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 64.0% -55.53% -9.54% 3.0% 2.0% -20.69% -13.23%
Zysk netto (%) 0.0% 0.0% 0.0% -8614.42% -17081.80% -1284.96% -2691.22% -2010.21% -3948.07% -2764.32% 0.0%
EPS -0.35 -0.58 -0.56 -0.31 -0.58 -0.27 -0.51 -0.3 -0.59 -0.20319 -0.44
EPS (rozwodnione) -0.35 -0.58 -0.56 -0.31 -0.58 -0.27 -0.51 -0.3 -0.59 -0.20319 -0.44
Ilośc akcji (mln) 193 193 193 176 193 182 193 188 194 194 194
Ważona ilośc akcji (mln) 193 193 193 176 193 182 193 188 194 194 194
Waluta HKD HKD HKD HKD HKD HKD HKD HKD HKD CNY HKD